HyQure BioTech offers a one-stop biosafety service platform for large-molecule drugs and cell & gene therapies (CGT), backed by EU QP audit, CNAS accreditation, and ISO9001 certification, meeting NMPA, FDA, and EMA requirements. The company has served 400+ biopharma firms, supported 150+ IND/BLA filings (65+ overseas), and provides viral clearance validation, cell bank characterization, commercial batch release testing, replication-competent virus detection (RCL, rcAAV, RCR), as well as HCD/HCP kit development and testing.
Professional team
Covering the full lifecycle of biotherapeutics
8000m2
BSL2 Laboratory
150+
Approved Cases
400+
Biopharmaceutical clients
500+
Collaborated Pipelines
